Indirect presentation of MHC antigens in transplantation.

T cells can recognise foreign major histocompatibility complex (MHC) antigens by two distinct routes, either directly as intact molecules or indirectly as peptides after antigen processing. Danny Shoskes and Kathryn Wood review the evidence that indirect presentation of allopeptides may play a significant role in the events leading to the rejection or acceptance of allo- and xenografts.

[1]  H. V. van Houwelingen,et al.  Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize. , 1991, Journal of immunology.

[2]  J. Freed,et al.  MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation , 1990, The Journal of experimental medicine.

[3]  P. Halloran,et al.  THE SIGNIFICANCE OF THE ANTI–CLASS I RESPONSE , 1992, Transplantation.

[4]  J. Bradley,et al.  Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. , 1992, Immunology today.

[5]  P. Linsley,et al.  Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations , 1992, The Journal of experimental medicine.

[6]  P. Parham,et al.  Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule , 1990, The Journal of experimental medicine.

[7]  R. Lechler,et al.  The question as to why major histocompatibility complex (MHC) a antigens are uniquely powerful primary immunogens and in this respect differ from antigens of the minor systems , 2003 .

[8]  M. Thomsen,et al.  Corecognition of HLA-A1 and HLA-DPw3 by a human CD4+ alloreactive T lymphocyte clone , 1990, The Journal of experimental medicine.

[9]  M. Fukuzawa,et al.  Effect of cyclosporin A on T cell immunity I. Dose‐dependent suppression of different murine T helper cell pathways , 1989, European journal of immunology.

[10]  P. Morris,et al.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.

[11]  J. Fabre,et al.  Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. , 1993, Transplant immunology.

[12]  S. Emerson,et al.  ABSORPTION OF SHED I‐Ak AND H‐2Kk ANTIGENS BY LYMPHOID CELLS , 1982, Transplantation.

[13]  Austyn Jm.  Antigen uptake and presentation by dendritic leukocytes. , 1992 .

[14]  L. Brent,et al.  Presentation of alloantigens by host cells , 1986, European journal of immunology.

[15]  E. Sercarz,et al.  Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection , 1992, The Journal of experimental medicine.

[16]  N. Braunstein,et al.  T cell recognition of allopeptides in context of syngeneic MHC. , 1991, Journal of immunology.

[17]  A. Singer,et al.  T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. , 1984, Journal of immunology.

[18]  K. Lafferty,et al.  Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.

[19]  R. Superina,et al.  Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes , 1988, Nature.

[20]  B. Benacerraf,et al.  Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathway , 1981, European journal of immunology.

[21]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[22]  A. Singer,et al.  Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses. , 1984, Journal of immunology.

[23]  D. Anderson,et al.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP , 1989, The Journal of experimental medicine.

[24]  H. Auchincloss,et al.  EVIDENCE THAT MULTIPLE DEFECTS IN CELL‐SURFACE MOLECULE INTERACTIONS ACROSS SPECIES DIFFERENCES ARE RESPONSIBLE FOR DIMINISHED XENOGENEIC T CELL RESPONSES1 , 1992, Transplantation.

[25]  K. Welsh,et al.  Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients , 1979, The Journal of experimental medicine.

[26]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[27]  F. Bach,et al.  Differential function of major histocompatibility complex antigens in T-lymphocyte activation , 1976, Nature.

[28]  J. Fabre,et al.  Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation , 1992, European journal of immunology.

[29]  R. Pierson,et al.  Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse , 1990, The Journal of experimental medicine.

[30]  J. Fabre,et al.  Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides , 1992, The Journal of experimental medicine.

[31]  P. Parham,et al.  HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes , 1987, Nature.

[32]  F. Claas,et al.  Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. , 1989, The New England journal of medicine.

[33]  M. Dallman,et al.  Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway , 1991, The Journal of experimental medicine.

[34]  P. Iványi,et al.  A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules , 1991, The Journal of experimental medicine.

[35]  J. Bluestone,et al.  Cloned cytotoxic T lymphocytes that recognize an I-A region product in the context of a class I antigen , 1986, Journal of Experimental Medicine.

[36]  G. Macpherson,et al.  Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo , 1993, The Journal of experimental medicine.

[37]  B. Singh,et al.  T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice. , 1991, Journal of immunology.

[38]  G. Shearer,et al.  The human antimurine xenogeneic cytotoxic response. I. Dependence on responder antigen-presenting cells. , 1990, Journal of immunology.

[39]  J. Fabre,et al.  Stimulation of CD4+ T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Evidence of the indirect pathway of allorecognition in some strain combinations. , 1992, Transplantation.

[40]  R. Lechler,et al.  The molecular basis of alloreactivity. , 1990, Immunology today.

[41]  P. Kimmel,et al.  Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. , 1991, Transplantation.

[42]  J. Cerottini,et al.  Synthetic peptides as antigens and competitors in recognition by H-2- restricted cytolytic T cells specific for HLA , 1988, The Journal of experimental medicine.

[43]  P. Linsley,et al.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.

[44]  E. Sercarz,et al.  Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides , 1990, The Journal of experimental medicine.

[45]  B. Jordan,et al.  H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells. , 1986, Journal of immunology.

[46]  J. R. Batchelor,et al.  MEDIATION OF ACUTE BUT NOT CHRONIC REJECTION OF MHC‐INCOMPATIBLE RAT KIDNEY GRAFTS BY ALLOREACTIVE CD4 T CELLS ACTIVATED BY THE DIRECT PATHWAY OF SENSITIZATION , 1993, Transplantation.

[47]  M. Clerici,et al.  Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation. , 1990, Journal of immunology.

[48]  H. Weiner,et al.  Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain , 1992, The Journal of experimental medicine.

[49]  J. Howard,et al.  Genetic control of transplant rejection. , 1982, Transplantation.

[50]  Zhuoru Liu,et al.  T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules , 1992, The Journal of experimental medicine.

[51]  P. Stock,et al.  EVIDENCE FOR DIRECT AND INDIRECT PATHWAYS IN THE GENERATION OF THE ALLOIMMUNE RESPONSE AGAINST PANCREATIC ISLETS , 1991, Transplantation.

[52]  M. Clerici,et al.  Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. , 1990, Journal of immunology.

[53]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.